HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

NCT07546929 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: HP-211
DRUG: Placebo

Sponsor

Housey Healthcare ULC